Pharmarise Holdings Corp. · TSE:2796
Pharmarise — Investor Presentation (August 2011)
35 slides from Pharmarise's investor presentation, Aug 27, 2011
Slide 1: Company Information Session
(7 Pharmarise HOLDINGS Ph harmarise 4) Hole ae gs Company Information Sessioi D7P-VPA KRW 4Y IAA eS tthWAS ae can 3723485278 JASDAQ SE$1—K : 2796
Slide 2: Contents
Pharmarise Holdings Company Information Session SHR (7 Pharmarise HOLDINGS Contents o mii 07 Selene 1 ACE eHS 0 ARBRE
Slide 3: Pharmarise Holdings
(2 Pharmarise HOLDINGS Pharmarise Holdings V1 SHRAAA
Slide 4: Company profile
( Pharmarise a HOLDINGS Sime tt 8% DP-VIA AK FavI ARASH Pharmarise Holdings Corporation A tt 7164-0011 RRABhHKPR1T B38815 RE RMR AEP FRA am 198476A BA 815,545 (201146531 BRE) (RAR GER SD) 799% (5 SSeR6N4 272) GHG : 201147531 BRE) EKOBRAS HRA AKO PARAS ORES (Sta) S820 (201 158A) = ST ID—-P E11 95/15
Slide 5: Business description
SAO Sime CREED RRBSSRCMHOMACRS (14) RR Sexi EYED RRB RE SEC Schaal aOR iia CELE (A) view skla Gi () ba) SEF SME Zh ETH) ICARDA EAAM GRIP N54 ARS IRA APT) ZERIT (4) ARVEEBAAl BY 9 — Ge (Me) ROE YS —) e Fatt ORE ERO (4) LY CLA RSeMNS Ht | yt > (tk) RRMEDS IP —VS41 A (MH) (CHS BES | LED REBHIO (#8) MRE
Slide 6: Group structure (as of August 2011)
PD \L—FiRK (201188 A 8) SiRe TIV—PEAKC 1 95 aH HEN — ZA 1 65 /58H) ATAU 7) L—-7 TER OAKS DP-VS4 2h) CAEN 27 -Vo1 ZEB WLR PABIG100% BASIOSAG GRE) | TORRR IIR F iw) tak [ FE CR) a 1k a SES 1958 Ree Ne a) APSRIS100% BASSES dom) | 777 (A) BRERA LY 9 — KE) See 4k PARE68.2% BASIE Grae) | ARE IP-VS4t An WF
Slide 7: Growth history and M&A
(2 Pharmarise HOLDINGS SHrHaZze (sa) FN TE LO HE M&A ARE PURGE -M&A 30 204 DUETS (BES) 500 194 cSMNeLRS (BB) 20105 He 7 <S HS) TASES (BS) oR 2) DiRRIBES Cis) &<5 SSRIS Ue) 45 2) 1/5 a0) 58 FHS (RB) 8A KAS (BU) Blak Fa} ie} i S 2004 2005 70068 20078 20088 209% 2O108F 201 1 2012 2010 FPS FES (ESL!) SA
Slide 8: Pharmarise Holdings
(2 Pharmarise HOLDINGS Pharmarise Holdings V1 SHRAEA
Slide 9: (BZ Pharmarise
(BZ Pharmarise an) sans RPA (COS REAYHORAI. DWS3-7—-—yarie ae Baal. ICE CO ROSNEST Pharmarise Holdings Corporation Company Information Session
Slide 10: ( Pharmarise
( Pharmarise Va HOLDINGS Pharmarise Holdings Corporation Company Information Session
Slide 11: an © HBSRaael
an © HBSRaael Pharmarise Holdings Corporation Company Information Session
Slide 12: ( Pharmarise
( Pharmarise id HOLDINGS 2S @ ite ROLE Se ateae “EO+A—DVIA— > HbR REBAL CUSIE SHC. MARAE 4 O— A oj RE hm, ) DSL Ya REIICB NAMED AER BR cha (45) 600 650 500 556 400 ——__________| 47] 300 338 200845F 200945 201045F 2011465R 201 24¢5F (+H) Pharmarise Holdings Corporation Company Information Session
Slide 13: Business environment (1)
( Pharmarise id HOLDINGS #8 6) Vo RY IAORWAA (1) RHR oo (VLRUY7) OP AA este lett REEORAO SB REEROVOMWL PST OCBEODS 20 BLU RE OO Ae 2SLED sb PRR ADD Te PRICED D oie BRCLERADHABD Ie BSrtcHAMGvI= eOtth ROS (BEL /%) 37.6 HHKAAARAMMS EER ROKK RAH (200841 1 A20AER) LH) Pharmarise Holdings Corporation Comp
Slide 14: Business environment (2)
EB 6) Vo RY IAORW AA (2) SEiateae MEER BOAO (REEMR I (CIDE HERD TRU YI ORE SHOU LRU YD Roose RE Onh-LXN—YAORRBROSROAR OnAAHiNROSSls mA AsHii< SSL< sR sHihATRAAOBR CEMFHEASHARORRAR CFDS HESUART—T OBRCT OBR OBWARO RAR OQBUWRRT—I OBREE OBR @RELT—I OBRAR ORARKE CORELT —I DARL EZ OBR ORLHtMROBRAR OmeUSOF
Slide 15: Business environment (3)
#8 6) Vo RY IADR AA (3) BAH | (RECUR MRE CA SHRI LRUYISRELCSA C PANICRUMD Ste lal hosRERROWHMS ASN—A) Lh - Biwinn KRUPA ‘ : e BERECEI< REIN, se HRUIAUYIERE _@- . ° 20.2 WRBICITL HEI TAVYTIO Si ESE 199 e ery 4 BEORARICIDWUT ELIVYT 5 KHA AARTT Ry IRR BS 200745A 2008465A 2009%5A 2010%5F 2011465A Pharma
Slide 16: Growth strategy (1)
HOLDINGS (eZ Pharmarise FTC TSEE ea SEBE (1) — MRSA NE + = ATR HERE S HERMOSS [ATI ANTO) Phar ¢ Holdings Corpor n
Slide 17: Growth strategy (2)
(BZ Pharmarise FTC TSEE DEBE (2) [53 —FABR Son] PRES AAS. MBN ES zi l CWS MICRMICB IC AMM Cee NceRAS URYEPAF FAL POVEMVUMITHWSET aA COBRA HT 20112F5AHOse Liald 1 (21 0075F (Hb 150%) Pharmarise Holdings Corporation Company Information Session
Slide 18: Strengths (1)
(BZ Pharmarise SAL O FC HHO HI (1) my RHIGTLL COMM ALIS. : DSHS PHAPWARS C en SALUBL CesT Pharmarise Holdings Corporation Company Information Session
Slide 19: Strengths (2)
( Pharmarise ia HOLDINGS SEALED RCHRO Ele (2) ane sep 8 = CHE RGHE STEP 5 Att3BGHE STEP 4 RBBBALLT TUE STEP 3 OTHE Ene J MAS I+0—-7y THE STEP 2 STAT RUHE sTeP | ~ (SHE) ata 15 28 388 Pharmarise Holdings Corporation Company Information Session
Slide 20: Strengths (3)
( Pharmarise ia HOLDINGS Sea eAeO Fees CHO 7c (3) = coo Waa Pp ILAas IN—TI7 bE AAA IE Ade Ate se 52 AR 1 4 (2002) 8A SLUP ORE C134 (SBR BRS 12) 15 PRUE TLV Fh O SAT ROBE KIVYT UN BEOFICRM ESRC FIESNKBAISZA (EV -/ hE Ce BE) DP-NVFTATW—-F AVY FY SRERR BK 20085 6RS817 (2 MLAS AEF TOIT INE sf Pharmarise
Slide 21: Strengths (4)
CG ¥ Pharmarise HOLDINGS SDA O Fe CHO EHC (4) SateAE Pharmarise Holdings Corporation Company Information Session
Slide 22: Pharmarise Holdings
(2 Pharmarise HOLDINGS Pharmarise Holdings DVT SHRAEA
Slide 23: ( Pharmarise
( Pharmarise ia HOLDINGS St T)L—-TFOMET X-Y SHOBSIML. MANET STC, BNUCRMEWEELT S ALR Rn WReHA CES MIRROR GOSS 4 ULC Ay kel SORMOMZ v | \ FRA Pharmarise Holdings Corporation Company Information Session
Slide 24: ( Pharmarise
( Pharmarise ia HOLDINGS 6 DORA SHOBSICHL. BRNST SEC, BN RMR S ALR Rn FHoO#BSIc Wd ZBEOS TTL) 2 aa BF I ORB fen Sy ea TOLLE EOL 3 Fett d SHES Pharmarise Holdings Corporation Company Information Session
Slide 25: (7 Pharmarise
(7 Pharmarise ALSO KS PWFT SY KBE DP-VIARZISYREMLAITS HoMICHIFSRAEZEMLENS . W/IN\DRBIE Pharmarise Holdings Corporation Company Information Session
Slide 26: (7 Pharmarise
(7 Pharmarise EBERT SAIWISYASR (20118 ABR) AE BES HeAD KSI UNBR een x0 eis! A aL HbERITIFD ERR 7) FREES (Rew? 1 RE MEET) me SO%DLE 40% LES 0% ARIE | 40% ony 65.4% (FRR225F 1 2ARABI4) Pharmarise Holdings Corporation Company Information Session
Slide 27: ( Pharmarise
( Pharmarise HOLDINGS DT IL—FHERO IS VEE ALR RH AAKB AGI ET IV— FIRE Bk C ee DWF PA e MRA GMHE I } POSE eels oe ae 7 Feaei guewas BRAS IEA SEAS Pharmarise Holdings Corporation Company Information Session
Slide 28: (ZB Pharmarise
(ZB Pharmarise DP-VI>I7T ARBRE) (BE) 4 Mh DP-VI1ARRE IL 2 EB BS tt Dr-VotAh) Pr € th SLOT REALS RT BS JIRID—-ADAAP IVE DIESB7~MWSBD R = FLMRERARIF (th) SRIGEOF At) EB tw BS FU=y710, 32. 181. SOS st18 R235 ce LB: 48085 (107A“—2) Bsr: 5280 Pharmarise Holdings Corporation Company Information Session
Slide 29: cpARBYIC
cpARBYIC Mika Seri. Ble Y—ERABALE BMeBiEs
Slide 30: Shareholder benefits
BS aslSisS (COC (MB) ALR RH ARATE *FM2343A 288 RRFATEL 4,7 008K (HERERIEIC ML T 23.15%) arb PRR 470BAF AZAROBE PMA al KORA aS alse WWIECP< 1.100KK (AL IarEAHEX OD BESREeAT EH) WNT IILAYh 1,100 RIL ARO RESETS) pig) 1.100K = GRSILKO RSE) ee 1.000% SMR) “WPM 200K CEREKOMRIEER) 20th 200K Pharmarise Hold
Slide 31: Pharmarise Holdings
(2 Pharmarise HOLDINGS Pharmarise Holdings DVT SHRAEA
Slide 32: Results for fiscal year ended June 2011
( Pharmarise ia HOLDINGS Wt RB/\TITh (2011425888) AER -— © BURARHELEMBARER (=A, IED 7 —\. ACH) — © *LRERE—ILICKSINAEDI — © Br Sst Lo inact — © tA DROME (AT —ILXUY hORER) 6 ea — © Rat ORA HER. VIRUY 7 OPE) 7 — © BEWXOUS SRA CERT) At BAA % 2010%5A 2011465A TLs 23,416 26,825 Be tlig 982 1,496 Flat 773
Slide 33: Forecast for fiscal 2012
(2 Pharmarise HOLDINGS RARE Ete si 48 (2012425A) RIVA J POINT: . @ 18/281 ,549875E : BRFESEL+2% CSTR 1 OSS (HEAR 204 (588) © SF ZS 0088 1 326A : A -WROMEC+HRMOMA+ESMROUS Ot*tLBRBEIVO/JONDRMEY FY —-SRICAIERUEY Bt / BAA % 201125A 201 24655 (P48) {O's {USE TL 26,825 14.6 28,374 5.8 Berle 1,496 52.3 1,6
Slide 34: ( Pharmarise
( Pharmarise ia HOLDINGS ACY BRIS DUT BME BAS BROKRICAIE PRN GAS BREDRODA. LEVMRI4OREIBHS (PF) ESS) aes ——8 este (%) 3000 — —50 2500 — _ 40 2000 — — 30 1500 — —20 1000 — 500 — ~ 10 2005 2006 2007 2008 2009% 2010 2011 2012 SARA SARA SARA SARA SARA SARA SAR SARA CPE) Pharmarise Holdings Corporation Co
Slide 35: Pharmarise Holdings
Pharmarise HOLDINGS ABIESITUUI, PICDUMEDCAUELTE. R—-LN—VbEIECH PSL). http://www.pharmarise.com/
Pharmarise Holdings — Investor Presentation (August 2011) on 6ix